Immunoinformatics Study: Multi-Epitope Based Vaccine Design from SARS-CoV-2 Spike Glycoprotein

Abstract

The coronavirus disease 2019 outbreak has become a huge challenge in the human sector for the past two years. The coronavirus is capable of mutating at a higher rate than other viruses. Thus, an approach for creating an effective vaccine is still needed to induce antibodies against multiple variants with lower side effects. Currently, there is a lack of research on designing a multiepitope of the COVID-19 spike protein for the Indonesian population with comprehensive immunoinformatic analysis. Therefore, this study aimed to design a multiepitope-based vaccine for the Indonesian population using an immunoinformatic approach. This study was conducted using the SARS-CoV-2 spike glycoprotein sequences from Indonesia that were retrieved from the GISAID database. Three SARS-CoV-2 sequences, with IDs of EIJK-61453, UGM0002, and B.1.1.7 were selected. The CD8+ cytotoxic T-cell lymphocyte (CTL) epitope, CD4+ helper T lymphocyte (HTL) epitope, B-cell epitope, and IFN-γ production were predicted. After modeling the vaccines, molecular docking, molecular dynamics, in silico immune simulations, and plasmid vector design were performed. The designed vaccine is antigenic, non-allergenic, non-toxic, capable of inducing IFN-γ with a population reach of 86.29% in Indonesia, and has good stability during molecular dynamics and immune simulation. Hence, this vaccine model is recommended to be investigated for further study.

Bioinformatics and immunoinformatics assisted multiepitope vaccine construct against Burkholderia anthina

“…Multi epitope-based vaccine construct can generate specific and strong immune responses against pathogens based on different multiple conserved, antigenic epitope sequences, and it can avoid adverse reactions against selected epitopes ( Umitaibatin et al, 2023 ). The application of reverse vaccinology, immunoinformatics, and different biophysical approaches for designing multi-epitope based vaccine construction against viral and bacterial species is becoming progressively popular because it can meaningfully save time and expenses in the development of vaccine construct against specific pathogens ( Leow et al, 2021 ).…”

Immuno-informatics study identifies conserved T cell epitopes in non-structural proteins of Bluetongue virus serotypes: formulation of a computationally optimized next-generation broad-spectrum multi-epitope vaccine

“…Given that our vaccine is a novel protein with altered antigen presentation characteristics compared to the native protein, the chosen linkers serve to ensure efficient confirmation, cleavage, and presentation of T cell epitopes by MHC molecules on antigen-presenting cells. The linkers utilized in our design are standard choices widely employed by researchers for developing multi-epitope vaccines ( 67 , 71 , 93 ). Moreover, the vaccine constructs using these linkers are also validated experimentally ( 50 ).…”

Development and Evaluation of an Immunoinformatics-Based Multi-Peptide Vaccine against Acinetobacter baumannii Infection

“…In the last few years, there has been a significant increase in the publication of immunoinformatic-based vaccines against various pathogens [20,21]. However, few have been assessed for their immunogenicity and protectivity in vivo.…”